3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
12
Recruiting
7
Unknown
4
Active not recruiting
3
Not yet recruiting
2
Withdrawn
1
Terminated
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Neoplasms
33
Breast Neoplasms
25
Colorectal Neoplasms
20
Prostatic Neoplasms
18
Uterine Cervical Neoplasms
13
Anxiety Disorders
13
Brain Neoplasms
7
Urinary Bladder Neoplasms
6
Lymphoma, Follicular
6
Lung Neoplasms
6
Colonic Neoplasms
6
Pain
5
Depression
5
Carcinoma, Hepatocellular
5
Uterine Cervical Dysplasia
4
Ovarian Neoplasms
4
Motor Activity
4
Inflammation
4
Head and Neck Neoplasms
4
Epilepsy
4
Dementia
4
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
3
Smoking
3
Sarcoma
3
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Neoplastic Syndromes, Hereditary
3
Lymphoma
3
Interventions
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Enrolling by invitation
×
Intermittent Fasting
×
Clear all
NCT06645093
2026-03-10
FasteStudien
University of Oslo
Phase NA
Enrolling by invitation
40 enrolled